Femera Life Sciences And Healthcare Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth 181.35%
- Ebitda -51.54%
- Net Worth 14.10%
- Total Assets 2.51%
About Femera Life Sciences And Healthcare
Femera Life Sciences And Healthcare Private Limited (FLSAHPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 08 March 2018 (Six years and 11 months 3 days old ). Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Anil Bharati, Gayatri Bharati, Dattatraya Bharati, and Two other members serve as directors at the Company.
Company Details
-
Location
Pune, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999PN2018PTC175224
-
Company No.
175224
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
08 Mar 2018
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Femera Life Sciences And Healthcare?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anil Bharati
|
Director | 08-Mar-2018 | Current |
|
Gayatri Bharati
|
Director | 08-Mar-2018 | Current |
|
Dattatraya Bharati
|
Director | 08-Mar-2018 | Current |
|
Manorama Sharma
|
Director | 18-Feb-2023 | Current |
|
Kanchan Agrawal
|
Director | 10-Mar-2023 | Current |
Financial Performance of Femera Life Sciences And Healthcare.
Femera Life Sciences And Healthcare Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 181.35% increase in profit. The company's net worth Soared by an impressive increase of 14.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Femera Life Sciences And Healthcare?
In 2021, Femera Life Sciences And Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Femera Life Sciences And Healthcare?
Unlock and access historical data on people associated with Femera Life Sciences And Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Femera Life Sciences And Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Femera Life Sciences And Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.